NRS639.2809. Implementation, monitoring and modification of drug therapy by pharmacist: Restrictions; notice; regulations.

      1.  Written guidelines and protocols developed by a registered pharmacist in collaboration with a practitioner which authorize the implementation, monitoring and modification of drug therapy:

      (a) May authorize a pharmacist to order and use the findings of laboratory tests and examinations.

      (b) May provide for implementation, monitoring and modification of drug therapy for a patient receiving care:

             (1) In a licensed medical facility; or

             (2) If developed to ensure continuity of care for a patient, in any setting that is affiliated with a medical facility where the patient is receiving care. A pharmacist who modifies a drug therapy of a patient receiving care in a setting that is affiliated with a medical facility shall, within 72 hours after implementing or modifying the drug therapy, provide written notice of the implementation or modification of the drug therapy to the collaborating practitioner or enter the appropriate information concerning the drug therapy in an electronic patient record system shared by the pharmacist and the collaborating practitioner.

      (c) Must state the conditions under which a prescription of a practitioner relating to the drug therapy of a patient may be changed by the pharmacist without a subsequent prescription from the practitioner.

      (d) Must be approved by the Board.

      2.  The Board may adopt regulations which:

      (a) Prescribe additional requirements for written guidelines and protocols developed pursuant to this section; and

      (b) Set forth the process for obtaining the approval of the Board of such written guidelines and protocols.

      (Added to NRS by 2011, 3077)